Provided by Tiger Fintech (Singapore) Pte. Ltd.

Enveric Biosciences

1.73
+0.09005.49%
Post-market: 1.72-0.0100-0.58%19:46 EDT
Volume:85.84K
Turnover:146.93K
Market Cap:3.30M
PE:-0.07
High:1.78
Open:1.69
Low:1.63
Close:1.64
Loading ...

Company Profile

Company Name:
Enveric Biosciences
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
7
Office Location:
4851 Tamiami Trail N,Suite 200,Naples,Florida,United States
Zip Code:
34103
Fax:
- -
Introduction:
Enveric Biosciences, Inc., a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. Its lead product candidates are EB-002, an active metabolite of psilocybin, which is in preclinical development stage for the treatment of anxiety disorders; and EB-003 that is in preclinical development stage for the treatment mental health. The company also focuses on the development of cannabinoid conjugate molecules for the treatment of pain and cancer. Enveric Biosciences, Inc. is headquartered in Naples, Florida.

Directors

Name
Position
Joseph Tucker
Chief Executive Officer and Director
Michael D. Webb
Chairman of the Board
Frank Pasqualone
Director
George Kegler
Director
Marcus Schabacker
Director

Shareholders

Name
Position
Joseph Tucker
Chief Executive Officer and Director
Kevin Coveney
Chief Financial Officer
Peter Facchini
Chief Innovation Officer